• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.

作者信息

Kneteman Norman, Livraghi Tito, Madoff David, de Santibañez Eduardo, Kew Michael

机构信息

Division of Transplantation, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Liver Transpl. 2011 Oct;17 Suppl 2:S117-27. doi: 10.1002/lt.22334.

DOI:10.1002/lt.22334
PMID:21584926
Abstract
摘要

相似文献

1
Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.用于监测等待肝移植及肝移植后肝细胞癌患者的工具。
Liver Transpl. 2011 Oct;17 Suppl 2:S117-27. doi: 10.1002/lt.22334.
2
Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?肝细胞癌的肝移植标准在尸体供肝和活体供肝中是否应该有所不同？
Liver Transpl. 2011 Oct;17 Suppl 2:S133-8. doi: 10.1002/lt.22348.
3
Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?肝细胞癌降期后患者是否符合肝移植条件？
Liver Transpl. 2011 Oct;17 Suppl 2:S109-16. doi: 10.1002/lt.22335.
4
Which matters most: number of tumors, size of the largest tumor, or total tumor volume?哪一个最为重要：肿瘤数量、最大肿瘤的大小还是肿瘤总体积？
Liver Transpl. 2011 Oct;17 Suppl 2:S58-66. doi: 10.1002/lt.22336.
5
Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?在活体肝移植失败后，我们是否应该进行尸体供肝移植？
Liver Transpl. 2011 Oct;17 Suppl 2:S139-46. doi: 10.1002/lt.22328.
6
Selection criteria for patients with hepatocellular carcinoma in liver transplantation.肝移植中肝细胞癌患者的选择标准。
Transplantation. 2009 Aug 15;88(3):442-3; author reply 443. doi: 10.1097/TP.0b013e3181af385a.
7
Treatment of recurrent hepatocellular carcinoma after liver transplantation.肝移植后复发性肝细胞癌的治疗
Liver Transpl. 2011 Oct;17 Suppl 2:S162-6. doi: 10.1002/lt.22361.
8
Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?肝细胞癌微血管侵犯的标志物：我们目前的进展如何？
Liver Transpl. 2011 Oct;17 Suppl 2:S72-80. doi: 10.1002/lt.22368.
9
What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?对于肝移植背景下的肝细胞癌，最佳的分期系统是什么？
Liver Transpl. 2011 Oct;17 Suppl 2:S26-33. doi: 10.1002/lt.22352.
10
Immunosuppression and hepatocellular carcinoma.免疫抑制与肝细胞癌
Liver Transpl. 2011 Oct;17 Suppl 2:S159-61. doi: 10.1002/lt.22318.

引用本文的文献

1
AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision tool.甲胎蛋白（AFP）评分与地铁票2.0表现相似，可用于“ALL内部”的临床决策工具中。
JHEP Rep. 2022 Dec 5;5(2):100644. doi: 10.1016/j.jhepr.2022.100644. eCollection 2023 Feb.
2
Liver transplantation in hepatocellular carcinoma - should we perform downstaging?肝癌肝移植——我们应该进行降期吗？
Croat Med J. 2022 Aug 31;63(4):317-325. doi: 10.3325/cmj.2022.63.317.
3
Liver Transplant Imaging prior to and during the COVID-19 Pandemic.
COVID-19 大流行前后的肝移植影像学。
Biomed Res Int. 2022 Jan 12;2022:7768383. doi: 10.1155/2022/7768383. eCollection 2022.
4
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.肝细胞癌超出米兰标准的肝移植局部区域治疗结局的国际研究。
JHEP Rep. 2021 Jul 13;3(5):100331. doi: 10.1016/j.jhepr.2021.100331. eCollection 2021 Oct.
5
Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?乐伐替尼作为肝移植后复发性肝细胞癌的一线治疗：当前证据是否适用于这些患者？
World J Transplant. 2020 Nov 28;10(11):297-306. doi: 10.5500/wjt.v10.i11.297.
6
Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis.成功的局部消融桥接治疗对肝硬化合并肝细胞癌患者肝移植后长期生存的影响。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1819-1827. doi: 10.1007/s00432-020-03215-9. Epub 2020 Apr 30.
7
Favourable outcome of pathologic downstaging by locoregional treatment for hepatocellular carcinoma in liver transplantation.局部区域治疗使肝癌在肝移植中病理降期的有利结果。
Sci Rep. 2019 Jul 17;9(1):10386. doi: 10.1038/s41598-019-46871-9.
8
Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.他汀类药物的使用与肝移植患者肝细胞癌复发减少相关。
Sci Rep. 2019 Feb 6;9(1):1467. doi: 10.1038/s41598-018-38110-4.
9
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.中间型肝细胞癌的肝移植：一种适应性方法。
World J Gastroenterol. 2017 May 14;23(18):3195-3204. doi: 10.3748/wjg.v23.i18.3195.
10
Twenty years of Milan criteria: how far do we go.米兰标准二十年：我们走了多远。
Hepatobiliary Surg Nutr. 2016 Dec;5(6):488-491. doi: 10.21037/hbsn.2016.12.01.